Managed Account Advisors’s United Therapeutics UTHR Stock Holding History

Managed Account Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$8.15M	Sell	46,836 -2,456	-5%	-$442K	0.01%	1191
2015 Q1	$8.5M	Buy	49,292 +3,103	+7%	+$473K	0.01%	1157
2014 Q4	$5.98M	Sell	46,189 -122,690	-73%	-$15.8M	0.01%	1309
2014 Q3	$21.7M	Buy	168,879 +4,343	+3%	+$448K	0.02%	649
2014 Q2	$14.6M	Buy	164,536 +10,677	+7%	+$1.03M	0.02%	831
2014 Q1	$14.5M	Sell	153,859 -266,552	-63%	-$27.3M	0.02%	791
2013 Q4	$47.5M	Buy	420,411 +42,529	+11%	+$3.84M	0.06%	330
2013 Q3	$29.8M	Sell	377,882 -29,794	-7%	-$2.18M	0.04%	450
2013 Q2	$26.8M	Buy	+407,676	New	+$26.3M	0.04%	460

Other funds holding UTHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Managed Account Advisors's UTHR Position: Q2 2015 in Review

Managed Account Advisors reduced its United Therapeutics (UTHR) stake by 5% in Q2 2015, selling an estimated $442K and leaving 46,836 shares worth $8.15M. The position accounts for 0.01% of the portfolio, ranked #1191.

Managed Account Advisors first reported a position in UTHR in Q2 2013 and has held it in 9 quarters since. The position peaked at $47.5M in Q4 2013. 383 funds tracked by Wall St. Rank hold UTHR as of Q2 2015.

Managed Account Advisors held 46,836 shares of United Therapeutics worth $8.15M as of Q2 2015.
Managed Account Advisors sold 2,456 United Therapeutics shares in Q2 2015, an estimated $442K.
United Therapeutics made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1191 holding.
Managed Account Advisors first reported a position in United Therapeutics in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's United Therapeutics position peaked at $47.5M in Q4 2013.
383 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.